Event 
Partner 
Milestone 
2020-11-17
ACT Genomics Have Been Awarded With ISO/IEC 27001 Certification
The ISO/IEC 27001 certification helps to increase clients’ confidence in our information security management, enabling us to promote innovative cancer genomic profiling services with our international partners.
Place:
Taiwan
2020-11-17
ACT Genomics Is The Member Of The Global Alliance For Genomics And Health (GA4GH)
ACT Genomics is now an organizational member of the Global Alliance for Genomics and Health (GA4GH) and we will continue to promote cancer precision medicine.
Place:
Taiwan
2020-11-10
Teddy Lab, A Central Lab Partner Of ACT Genomics, And AstraZeneca China Signed Strategic MOU To Develop Cancer Precision Medicine Solution In China
Teddy Lab and AstraZeneca China signed strategic MOU for the CDx development of HRD, the standardization of sequencing and commercialization to provide cancer patients precision diagnosis and treatment as one-stop service.
Place:
China
2020-10-22
11/07 & 08 Upcoming Annual 7th Hong Kong International Oncology Symposium
ACT Genomics co-organizes the 7th Hong Kong International Oncology Symposium (HKIOS) to invite experts to share their first-hand experience with this groundbreaking advances in cancer management to speed up the progress of clinical practice.
Place:
Hong Kong
2020-09-29
ACT Genomics and Nan Shan Life Insurance Cooperates To Promote High-Quality Cancer Precision Medicine Services
To provide better care for cancer patients in precision medicine, strategic cooperations among biotech and insurance company are on the rise. We are happy to announce that ACT Genomics cooperates with Nan Shan Life Insurance for precision medicine project
Place:
Taipei
2020-09-28
ACTRisk™ Genetic Test For Hereditary Cancers - Start You & Your Family's Hereditary Medical Plan Better And Earlier
Approximately 5–10% of cancers are caused by inherited genetic mutations, and through high-quality hereditary genetic test ACTRisk™ , you and your family can start your hereditary medical plan better and earlier.
Place:
Taipei
2020-09-07
ACT Genomics Completed the First Closing of latest Round of Equity Financing
ACT Genomics is pleased to announce the completion of the first closing of the latest round of equity financing from a group of strategic investors including Aflac Ventures LLC and Kyoto University Innovation Capital.
Place:
Asia
2020-07-28
Information Security Policy
Strengthen personnel knowledge and ability, avoid data leakage and ensure that services are available
Place:
Taiwan
2020-06-20
A Joint Clinical Research Collaboration among ACT Genomics, Kaohsiung Medical University (KMU), and National Health Research Institutes (NHRI) Seeks to Investigate the Genomic Landscape of Melanoma in Taiwan
ACT Genomics, Kaohsiung Medical University (KMU), and National Health Research Institutes (NHRI) launched a joint clinical research collaboration aimed to establish comprehensive genomic profiles of Melanoma within the Taiwanese population
Place:
Taiwan
2020-06-05
ACT Genomics Is At A Fresh Turning Point Under COVID-19 In 2020 US BIO Digital
ACT Genomics is chosen by Taipei City Government as representative to join US BIO Digital, the world’s largest biotechnology exhibition, with OBI Pharma, belxbiopharma, NatureWise Biotech & Medicals, Far East Bio-tec and AcroMass Technology.
Place:
Taipei
